Intelligence · Clinical Development
Pipeline search results
Programs matching “treatment” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 270 pipeline programs matching "treatment" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
RA-TL011-101
Teva Pharma GmbH
Rheumatoid Arthritis
1 trial -
RT-114 is the RaniPill capsule with PG-102 for the treatment of obesity
Rani Therapeutics Holdings
Obesity
1 trial -
SPN-817, Treatment B
SUPERNUS PHARMACEUTICALS, INC.
Healthy Volunteer
1 trial -
SUITH
The George Institute
Stress or mixed urinary incontinence in women over 50 years of age not responding to conventional treatments
1 trial -
Sativex® (Treatment A)
Jazz Pharmaceuticals Ireland Limited
Healthy Subjects
1 trial -
TAK-385
Takeda
Hormone Treatment-naïve Participants With Prostate Cancer
1 trial -
TRAME-13-25
Lacuna Pharma Pty Ltd
Adjuvant treatment of BRAF V600E or V600K mutation-positive melanoma (in combination with dabrafenib);, BRAF V600E mutation-positive unresectable or metastatic solid tumors;, BRAF V600E mutation-positive metastatic non-small cell lung cancer (NSCLC), in combination with dabrafenib;, BRAF V600E mutation-positive low-grade glioma (LGG)., BRAF V600E mutation-positive locally advanced or metastatic anaplastic thyroid cancer (ATC);, BRAF V600E or V600K mutation-positive unresectable or metastatic melanoma, as a single agent in BRAF-inhibitor treatment-naïve patients or in combination with dabrafenib;
1 trial -
Treatment A
Tonix Pharmaceuticals Holding
Healthy Adults
1 trial -
Treatment A
Pfizer
Asthma
1 trial -
Treatment A
Pfizer
Healthy
1 trial -
Treatment A
Tonix Pharmaceuticals Holding
Healthy
1 trial -
Treatment A (rosuvastatin)
LEXICON PHARMACEUTICALS, INC.
Healthy
1 trial -
Treatment A digoxin
LEXICON PHARMACEUTICALS, INC.
Healthy
1 trial -
Treatment A-Bemnifosbuvir/Ruzasvir FDC administered fasting
Atea Pharmaceuticals
Healthy Volunteer Study
1 trial -
Treatment A: Fp MDPI
Teva Pharma GmbH
Asthma
1 trial -
Treatment as usual (TAU)
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Abuse
1 trial -
Treatment sequence AB
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial -
Trial of the novel peroral anti-tumor treatment in patients with solid tumors
Lacuna Pharma Pty Ltd
Metastatic or locally advanced solid tumors for which no standard therapy exists or standard therapy has failed: tumors of lung, head and neck, colon, stomach, esophagus, breast, ovary and/or fallopian tube or primary peritoneal high-grade serous carcinoma
1 trial -
Vancomycin Pre-Treatment
Seres Therapeutics
Allogeneic Hematopoietic Stem Cell Transplantation
1 trial -
anti-CD123 CAR-T treatment
Nanjing Legend Biotech Co.
Acute Leukemia
1 trial -
interceptive orthodontic treatments
NORTHWEST BIOTHERAPEUTICS INC
Malocclusion
1 trial -
treatment A
United Therapeutics Europe Ltd
Dyslipidemia
1 trial -
zlk20251119
Xiyuan Hospital of China Academy of Chinese Medical Sciences
DC-CIK Treatment
1 trial -
A8081075
Pfizer Australia Pty Ltd
This Master Protocol for Crizotinib Continuation Sub-Studies has been designed to provide continued treatment access for eligible participants who continue to derive clinical benefit from study intervention in a Pfizer sponsored crizotinib parent study that will be closed
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.